April 2nd 2024
The company plans to announce full market availability of the RenaFlex ureteroscope system at a later date.
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Ureteroscopy vs. shock wave lithotripsy: Advances spell positive future for both
October 3rd 2013In this interview, Brian R. Matlaga, MD, MPH, discusses factors to consider in the decision to utilize ureteroscopy versus shock wave lithotripsy, how to counsel patients on the optimal approach, how to minimize the morbidity of each modality, and why younger urologists are more likely to perform ureteroscopy.
Kidney stones linked to heart disease risk in women
July 29th 2013An analysis of data from three studies that involved a total of more than 240,000 participants found that a self-reported history of kidney stones was associated with a statistically significant increased risk of coronary heart disease among women.
AUA 2013: Study: Women can take two steps to lower stone risk
May 4th 2013Postmenopausal women may reduce their risk of incident kidney stone disease by engaging in physical activity and avoiding excessive caloric intake, analyses of data collected in the Women’s Health Initiative Observational Study show.
Stone disease studies examine multiple causes
April 30th 2013With rates of stone disease on the rise in the U.S., researchers have turned their attention to possible causes. New research exploring the possible influence of diabetes, diet, and even being a surgeon will be presented at the upcoming AUA annual meeting.
Percutaneous nephrolithotomy: Tricks and tips for access and stone removal
January 1st 2012Although percutaneous nephrolithotomy (PCNL) comprises only 4% to 6% of all stone surgeries, it behooves the urologist with an interest in stone disease to be facile in this treatment modality in order to offer patients the most appropriate and effective treatment for their stones.